TITLE

A half-site of the p53-binding site on the keratin 14 promoter is specifically activated by p63

AUTHOR(S)
Cai, Bi-He; Chao, Chung-Faye; Lu, Mei-Hua; Lin, Hwang-Chi; Chen, Jang-Yi
PUB. DATE
July 2012
SOURCE
Journal of Biochemistry;Jul2012, Vol. 152 Issue 1, p99
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Three members of p53 family, p53, p63 and p73, can transactivate their specific target genes through a p53 consensus sequence-binding motif which consists with direct repeats of PuPuPuC(T/A)(T/A)GPyPyPy as a whole-site of p53-binding site. p63, an epidermal stem cells marker, can regulate epidermal development and differentiation, but p53 has no similar biological activity. One isoform of p63, TAp63α, can active an epidermal basal cell marker, keratin 14. However, the p53-binding site does not exist as a whole-site in the K14 promoter region, although it contains three putative p53 half-binding sites at −269 to −1 of the K14 promoter. Two of three putative half-sites of the p53-binding site can be bound by p63α by electrophoresis mobility shift assay and DNA affinity purification assay. Only mutation of the p53 half-binding site at −140 to −131, the TAp63α induced K14 promoter activity can be abolished. This half-site was specifically activated by p63, but not by p53. Once we extend this p53 half-site to a whole p53-binding site in K14 promoter, both p53 and p63 expression vectors can activate its activity. Therefore, we propose that the different length of p53-binding site would determinate the gene regulated by different p53 family proteins.
ACCESSION #
77686419

 

Related Articles

  • PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73. Rökaeus, N; Shen, J; Eckhardt, I; Bykov, V J N; Wiman, K G; Wilhelm, M T // Oncogene;12/9/2010, Vol. 29 Issue 49, p6442 

    The low molecular weight compound PRIMA-1 and the structural analog PRIMA-1MET, also named APR-246, reactivate mutant p53 through covalent binding to the core domain and induce apoptosis in tumor cells. Here, we asked whether PRIMA-1MET/APR-246 can rescue mutant forms of the p53 family members...

  • Loss of the Osteogenic Differentiation Potential during Senescence Is Limited to Bone Progenitor Cells and Is Dependent on p53. Despars, Geneviève; Carbonneau, Cynthia L.; Bardeau, Pascal; Coutu, Daniel L.; Beauséjour, Christian M. // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    DNA damage can lead to the induction of cellular senescence. In particular, we showed that exposure to ionizing radiation (IR) leads to the senescence of bone marrow-derived multipotent stromal cells (MSC) and osteoblast-like stromal cells (OB–SC), a phenotype associated with bone loss....

  • Stabilising the DNA-binding domain of p53 by rational design of its hydrophobic core. Kian Hoe Khoo; Andreas C. Joerger; Stefan M.V. Freund; Alan R. Fersht // PEDS: Protein Engineering, Design & Selection;Jul2009, Vol. 22 Issue 7, p421 

    The core domain of the tumour suppressor p53 is of inherently low thermodynamic stability and also low kinetic stability, which leads to rapid irreversible denaturation. Some oncogenic mutations of p53 act by just making the core domain thermosensitive, and so it is the target of novel...

  • A Pathogenic Mosaic TP53 Mutation in Two Germ Layers Detected by Next Generation Sequencing. Behjati, Sam; Maschietto, Mariana; Williams, Richard D.; Side, Lucy; Hubank, Mike; West, Rebecca; Pearson, Katie; Sebire, Neil; Tarpey, Patrick; Futreal, Andrew; Brooks, Tony; Stratton, Michael R.; Anderson, John // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Background: Li-Fraumeni syndrome is caused by germline TP53 mutations and is clinically characterized by a predisposition to a range of cancers, most commonly sarcoma, brain tumours and leukemia. Pathogenic mosaic TP53 mutations have only rarely been described. Methods and Findings: We describe...

  • Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. Goldberg, Zehavit; Sionov, Ronit Vogt; Berger, Michael; Vaara Zwang; Perets, Ruth; Etten, Richard Avan; Oren, Moshe; Taya, Voichi; Haupt, Ygal // EMBO Journal;7/15/2002, Vol. 21 Issue 14, p3715 

    The p53 tumor suppressor is inhibited and destabilized by Mdm2. However, under stress conditions, this downregulation is relieved, allowing the accumulation of biologically active p53. Recently we showed that c-Abl is important for p53 activation under stress conditions. In response to DNA...

  • Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer. Mohamadkhani, Ashraf; Naderi, Elnaz; Sharafkhah, Maryam; Fazli, Hamid Reza; Moradzadeh, Malihe; Pourshams, Akram // Journal of Oncology;2013, p1 

    The TP53 gene encodes tumor protein p53 which play a major role in the etiology of pancreatic cancer. The important role of codon 249 of TP53 for binding of p53 to its sequence-specific consensus site in DNA has been revealed by crystallography's studies, and mutation at this codon was detected...

  • Preexisting TP53 mutation in therapy-related acute myeloid leukemia. Schulz, Eduard; Kashofer, Karl; Heitzer, Ellen; Mhatre, Ketaki; Speicher, Michael; Hoefler, Gerald; Sill, Heinz // Annals of Hematology;Mar2015, Vol. 94 Issue 3, p527 

    The article presents a case study of a 71 year-old male Caucasian patient suffering from Hodgkin lymphoma treated with chemotherapy and radiotherapy. According to classification of the World Health Organization (WHO) therapy-related myeloid neoplasms caused due to mutational events in...

  • Mutant p53 Cooperates with Knockdown of Endogenous Wild-Type p53 to Disrupt Tubulogenesis in Madin-Darby Canine Kidney Cells. Zhang, Yanhong; Yan, Wensheng; Chen, Xinbin // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Mutation of the p53 gene is the most common genetic alteration in human malignances and associated clinically with tumor progression and metastasis. To determine the effect of mutant p53 on epithelial differentiation, we developed three-dimensional culture (3-D) of Madin-Darby canine kidney...

  • p53-Independent Cell Cycle and Erythroid Differentiation Defects in Murine Embryonic Stem Cells Haploinsufficient for Diamond Blackfan Anemia-Proteins: RPS19 versus RPL5. Singh, Sharon A.; Goldberg, Tracie A.; Henson, Adrianna L.; Husain-Krautter, Sehba; Nihrane, Abdallah; Blanc, Lionel; Ellis, Steven R.; Lipton, Jeffrey M.; Liu, Johnson M. // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Diamond Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome caused by ribosomal protein haploinsufficiency. DBA exhibits marked phenotypic variability, commonly presenting with erythroid hypoplasia, less consistently with non-erythroid features. The p53 pathway, activated by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics